Hookipa Pharma Inc Expected To Post A Loss Of 24 Cents A Share: Earnings Preview

Hookipa Pharma

13/05/2022 13:55

* HOOKIPA Pharma Inc  HOOK.OQ   HOOK.O  is expected to show
a rise
in quarterly revenue when it reports  results on May 16. 
    * The New York City-based  company is expected to report  a
174.1% increase in revenue to $14.532 million from $5.3 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for HOOKIPA Pharma Inc
is for
a loss of 24 cents per share. For the same quarter last year,
the company reported a loss of 53 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 2.0%
in the last three months. ​
    * Wall Street's median 12-month price target for HOOKIPA
Pharma
Inc is $7​, above​ its last closing price of $1.41. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.63       -0.58      -0.65     Missed  -12.3
 Sep. 30 2021  -0.52       -0.52      -0.61     Missed  -16.6
 Jun. 30 2021  -0.53       -0.53      -0.52     Beat    1.6​
 Mar. 31 2021  -0.52       -0.53      -0.53     Met     0.6
 ​​Dec.        -0.54       -0.58      -0.46     Beat    21.4
 31 2020                                                
 Sep. 30 2020  -0.44       -0.43      -0.53     Missed  -22.8​
 Jun. 30 2020  -0.49       -0.47      -0.28     Beat    40.1
 Mar. 31 2020  -0.46       -0.42      -0.43     Missed  -2.4
 This summary was machine generated May 13 at 12:55 GMT.  All
figures in US dollars  unless otherwise stated